Bridge to transplantation with the Jarvik-7 (CardioWest) total artificial heart: A single-center 15-year experience

Journal of Heart and Lung Transplantation

Volumn 22, Issue 12, 2003, Pages 1296-1303

  Leprince, P ^a,b   Bonnet, N ^a   Rama, A ^a   Leger P ^a   Bors, V ^a   Levasseur, J P ^a   Szefner, J ^a   Vaissier, E ^a   Pavie, A ^a   Gandjbakhch, I ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Service de Chirurgie Thoracique et Cardiovasculaire   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INOTROPIC AGENT;

ADULT; ARTICLE; ARTIFICIAL HEART; BLEEDING; BODY SURFACE; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEART TAMPONADE; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 10744223950     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(03)00036-6     Document Type: Article

References (26)

1. DeVries W.C., Anderson J.L., Joyce L.D., et al. Clinical use of the total artificial heart. N Engl J Med. 310:1984;273-278.
2. Copeland J.G., Levinson M.M., Smith R., et al. The total artificial heart as a bridge to transplantation. A report of two cases. JAMA. 256:1986;2991-2995.
3. Muneretto C., Rabago G. Jr, Pavie A., et al. Mechanical circulatory support as a bridge to transplantation current status of total artificial heart in 1989 and determinants of survival . J Cardiovasc Surg (Torino). 31:1990;486-491.
4. Kawaguchi A.T., Gandjbakhch I., Pavie A., et al. Factors affecting survival in total artificial heart recipients before transplantation. Circulation. 82:(suppl5):1990;IV322-327.
5. Arabia F.A., Copeland J.G., Pavie A., Smith R.G. Implantation technique for the CardioWest total artificial heart. Ann Thorac Surg. 68:1999;698-704.
6. Pavie A., Leger P., Regan M., et al. Clinical experience with a total artificial heart as a bridge for transplantation the Pitie experience . J Cardiac Surg. 10:1995;552-558.
7. Copeland J.G., Arabia F.A., Smith R.G., Covington D. Synthetic membrane neo-pericardium facilitates total artificial heart explantation. J Heart Lung Transplant. 20:2001;654-656.
8. Leprince P., Rahmati M., Bonnet N., et al. Expanded polytetrafluoroethylene membranes to wrap surfaces of circulatory support devices in patients undergoing bridge to heart transplantation. Eur J Cardiothorac Surg. 19:2001;302-306.
9. Szefner J. Control and treatment of hemostasis in cardiovascular surgery. The experience of La Pitie Hospital with patients on total artificial heart. Int J Artif Organs. 18:1995;633-648.
10. Copeland J.G., Szefner J. Anticoagulants and the artificial heart. Lewis T.G. Mechanical circulatory support. 1995;306-311 Edward Arnold, London.
11. Durandy Y, et al. Mediastinal infection after cardiac operation. A simple closed technique. J Thorac Cardiovasc Surg 1989;97:282-5.
12. Calvat S, et al. Closed drainage using Redon catheters for local treatment of poststernotomy mediastinitis. Ann Thorac Surg 1996;61:195-201.
13. Kawaguchi A., Muneretto C., Pavie A., et al. Hemodynamic characteristics of the Jarvik-7 total artificial heart. Circulation. 80:1989;III152-157.
14. Copeland J.G. III, Smith R.G., Arabia F.A., et al. Comparison of the CardioWest total artificial heart, the Novacor left ventricular assist system and the Thoratec ventricular assist system in bridge to transplantation. Ann Thorac Surg. 71:(suppl3):2001;S92-97.
15. Rose E.A., Gelijns A.C., Moskowitz A.J., et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med. 345:2001;1435-1443.
16. Schmid C., Deng M., Hammel D., et al. Emergency versus elective/urgent left ventricular assist device implantation. J Heart Lung Transplant. 17:1998;1024-1028.
17. Griffith B.P., Kormos R.L., Hardesty R.L., et al. The artificial heart infection-related morbidity and its effect on transplantation . Ann Thorac Surg. 45:1988;409-414.
18. Rice L.B., Karchmer A.W. Artificial heart implantation what limitations are imposed by infectious complications? JAMA. 259:1988;894-895.
19. Lonchyna V.A., Pifarre R., Sullivan H., et al. Successful use of the total artificial heart as a bridge to transplantation with no mediastinitis. J Heart Lung Transplant. 11:1992;803-810.
20. Copeland J.G., Arabia F.A., Smith R.G., et al. Arizona experience with CardioWest total artificial heart bridge to transplantation. Ann Thorac Surg. 68:1999;756-760.
21. Muneretto C., Solis E., Pavie A., et al. Total artificial heart survival and complications . Ann Thorac Surg. 47:1989;151-157.
22. Holman W.L., Davies J.E., Rayburn B.K., et al. Treatment of end-stage heart disease with outpatient ventricular assist devices. Ann Thorac Surg. 73:2002;1489-1493.
23. Kawaguchi A.T., Cabrol C., Gandjbakhch I., et al. Preoperative risk analysis in patients receiving Jarvik-7 artificial heart as a bridge to transplantation. Eur J Cardiothorac Surg. 5:1991;509-514.
24. Gronda E.G., Barbieri P., Frigerio M., et al. Prognostic indices in heart transplant candidates after the first hospitalization triggered by the need for intravenous pharmacologic circulatory support. J Heart Lung Transplant. 18:1999;654-663.
25. Gronda E., Mangiavacchi M., Frigerio M., et al. Determination of candidacy for mechanical circulatory support importance of clinical indices . J Heart Lung Transplant. 19:(suppl8):2000;S83-88.
26. Arabia F.A., Copeland J.G., Smith R.G., et al. CardioWest total artificial heart a retrospective controlled study . Artif Organs. 23:1999;204-207.